Manipulation of different ratio dependent approaches for determination of pravastatin in the presence of pioglitazone in pharmaceutical preparation
Authors:
- Nasr M El-AbasawiNENasr M El-Abasawi
- Khalid Am AttiaKAKhalid Am Attia
- Ahmad Am Abo-SerieAAAhmad Am Abo-Serie
- Ashraf Abdel-FattahAAAshraf Abdel-Fattah
Open Access
- 16 March 2018
- journal article
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 7 (2) , 1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 DiabetesDiabetes Care, 2010
- Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT studyAtherosclerosis, 2008
- Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor‐β1Cell Biology International, 2007
- Effect of Very High-Intensity Statin Therapy on Regression of Coronary AtherosclerosisJAMA, 2006
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997